SCHEMBL7866690

SCHEMBL7866690

O=C[C@H](Cc1c[nH]cn1)[N]C(=O)OCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
CTSB P07858 2/20 0.35
CTRB1 P17538 2/20 0.35
HCAR2 Q8TDS4 1/20 0.35
MAPK1 P28482 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
POLB P06746 1/20 0.34
MIF P14174 1/20 0.34
ROCK2 O75116 1/20 0.34
MBTPS1 Q14703 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7323732 0.81 ALDH1A1 (0.49) ALDH1A1CTSBCTRB1HCAR2MAPK1
SCHEMBL713212 0.76 LTA4H (0.44) ALDH1A1CTRB1KMT2A
SCHEMBL729057 0.76 LTA4H (0.44) ALDH1A1CTRB1KMT2A
Hydrochloric Acid SCHEMBL7273689 0.75 LTA4H (0.43) ALDH1A1CTRB1KMT2A
Hydrochloric Acid SCHEMBL7273682 0.75 LTA4H (0.43) ALDH1A1CTRB1KMT2A
Hydrochloric Acid SCHEMBL9515682 0.75 LTA4H (0.43) ALDH1A1CTRB1KMT2A
Hydrochloric Acid SCHEMBL9515675 0.75 LTA4H (0.43) ALDH1A1CTRB1KMT2A
SCHEMBL12483847 0.74 LTA4H (0.38) ALDH1A1CTRB1MAPK1POLBMBTPS1
SCHEMBL24795018 0.73 ITGB3 (0.53) CTSB
SCHEMBL4178755 0.73 ITGB3 (0.53) CTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077949-A2 COMBINATIONS OF PROTEIN FARNESYLTRANSFERASE AND HMG COA REDUCTASE INHIBITORS AND THEIR USE TO TREAT CANCER WARNER-LAMBERT COMPANY (US) 2001-02-28 EP claimed
WO-1999058505-A2 COMBINATIONS OF PROTEIN FARNESYLTRANSFERASE AND HMG COA REDUCTASE INHIBITORS AND THEIR USE TO TREAT CANCER WARNER-LAMBERT COMPANY (US) 1999-11-18 WO claimed